Warning letter
Yicheng Chemical Corp.: warning letter of Jan 1, 2018
FDA warning letter 539843 · Center for Drug Evaluation and Research
Key facts
| Reference number | 539843 |
|---|---|
| Company | Yicheng Chemical Corp. |
| Subject | CGMP/Active Pharmaceutical Ingredient (API)/Adulterated |
| Issue date | Jan 1, 2018 |
| Posted date | Jan 16, 2018 |
| Issuing office | Center for Drug Evaluation and Research |
| Product type | Drugs |
| Inspection city | Changzhou |
| Inspection start date | Jul 17, 2017 |
| Letter on fda.gov | fda.gov |
At a glance
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: